Company / FCF Margin
Tempest Therapeutics, Inc. FCF Margin History
FY2017-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-20041.5%
FY2017
5-year range
-20041.5% / -20041.5%
FY2017-FY2017
Trend
-
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-20041.5% in FY2017.
FCF Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.69 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | -20041.5% | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2017 · SEC 10-K · Updated Jun 28, 2026